IL-17A producing mast cells as therapeutic target in spondyloarthritis

IL-17A producing mast cells as therapeutic target in spondyloarthritis

Bibliographic Details
Main Authors:	Canete J, Tak P P, Noordenbos T, Gofita I, Yeremenko N, Baeten D
Format:	Article
Language:	English
Published:	BMC 2010-11-01
Series:	Journal of Translational Medicine

Similar Items

IL-17 producing mast cells contribute to synovial inflammation in non-psoriatic and psoriatic spondyloarthritis
by: Noordenbos Troy, et al.
Published: (2011-11-01)

A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis
by: Jacqueline E. Paramarta, et al.
Published: (2016-10-01)

IL-17 Inhibition: Emerging Perspectives in the Future Management of Axial Spondyloarthritis
by: Atul Deodhar, et al.
Published: (2015-07-01)

RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients
by: Koen Venken, et al.
Published: (2019-01-01)

Serum biomarkers to predict clinical response in proof-of-concept trials in spondyloarthritis
by: Turina Maureen, et al.
Published: (2011-11-01)

Whodunit? The Contribution of Interleukin (IL)-17/IL-22-Producing γδ T Cells, αβ T Cells, and Innate Lymphoid Cells to the Pathogenesis of Spondyloarthritis
by: Annika Reinhardt, et al.
Published: (2018-04-01)

The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis
by: Hiroyuki Tsukazaki, et al.
Published: (2020-09-01)

Novel therapeutic targets in axial spondyloarthritis
by: Worth, C, et al.
Published: (2018)

Innate Cells: The Alternative Source of IL-17 in Axial and Peripheral Spondyloarthritis?
by: Nicolas Rosine, et al.
Published: (2021-01-01)

Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis
by: Atzeni F, et al.
Published: (2021-05-01)

Mast cells in spondyloarthritis, more than simple inflammatory bystanders?
by: Laura Polivka, et al.
Published: (2020-11-01)

Relative overexpression of membrane-bound versus soluble TNF in spondyloarthritis
by: Ambarus Carmen A, et al.
Published: (2012-11-01)

The role of Bob1 in rheumatoid arthritis: potential implications for autoimmunity
by: Yeremenko Nataliya, et al.
Published: (2012-11-01)

Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis
by: Angela Ceribelli, et al.
Published: (2021-06-01)

IL-17+ Mast Cell/T Helper Cell Axis in the Early Stages of Acne
by: Yoan Eliasse, et al.
Published: (2021-09-01)

Characteristic Pattern of IL-17RA, IL-17RB, and IL-17RC in Monocytes/Macrophages and Mast Cells From Patients With Bullous Pemphigoid
by: Stéphane Nesmond, et al.
Published: (2019-09-01)

Intratumor IL-17-positive mast cells are the major source of the IL-17 that is predictive of survival in gastric cancer patients.
by: Xiaosun Liu, et al.
Published: (2014-01-01)

Dual Blockade of TNF and IL-17A Inhibits Inflammation and Structural Damage in a Rat Model of Spondyloarthritis
by: Ihsan Hammoura, et al.
Published: (2022-01-01)

Therapeutic potential of targeting IL‐17 and IL‐23 in sepsis
by: Markus Bosmann, et al.
Published: (2012-12-01)

TNF and IL-6 differentially regulate the production of DKK-1, a master regulator of bone remodelling, by fibroblast-like synoviocytes
by: Baeten D, et al.
Published: (2010-11-01)

IL-33 is produced by mast cells and regulates IgE-dependent inflammation.
by: Chia-Lin Hsu, et al.
Published: (2010-08-01)

Peptide-based vaccine targeting IL17A attenuates experimental spondyloarthritis in HLA-B27 transgenic rats
by: Tetsuya Tomita, et al.
Published: (2023-02-01)

Pathogenic Role of IL-17 and Therapeutic Targeting of IL-17F in Psoriatic Arthritis and Spondyloarthropathies
by: Guillermo Sánchez-Rodríguez, et al.
Published: (2023-06-01)

Targeting Mast Cells as a Viable Therapeutic Option in Endometriosis
by: David A. Hart
Published: (2017-08-01)

Should mast cells be considered therapeutic targets in multiple sclerosis?
by: Karen Henriette Pinke, et al.
Published: (2020-01-01)

The Role of the IL-23/IL-17 Axis in Disease Initiation in Spondyloarthritis: Lessons Learned From Animal Models
by: Mohamed Mandour, et al.
Published: (2021-06-01)

Targeting the Interleukin-23/Interleukin-17 Inflammatory Pathway: Successes and Failures in the Treatment of Axial Spondyloarthritis
by: Runsheng Wang, et al.
Published: (2021-09-01)

Interleukin-17–targeted treatment in patients with spondyloarthritis and associated cardiometabolic risk profile
by: Rubén Queiro, et al.
Published: (2023-07-01)

The IL-20 cytokine family in rheumatoid arthritis and spondyloarthritis
by: Kragstrup, T, et al.
Published: (2018)

The Interleukine-17 Cytokine Family: Role in Development and Progression of Spondyloarthritis, Current and Potential Therapeutic Inhibitors
by: Anna Davydova, et al.
Published: (2023-04-01)

Editorial: Genetic Studies on Spondyloarthritis: From Disease Predictors to Therapeutic Targets
by: Matteo Vecellio, et al.
Published: (2022-02-01)

The Jekyll and Hyde story of IL17 producing γδT (Tγδ17) cells
by: Rushikesh Sudam Patil, et al.
Published: (2015-02-01)

Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives
by: Farhad Seif, et al.
Published: (2023-03-01)

PGD2, IL-1-Family Members and Mast Cells
by: A. Anogeianaki, et al.
Published: (2010-09-01)

The role of Th-17 cells and IL-17 in the metastatic spread of breast cancer: As a means of prognosis and therapeutic target
by: Tewodros Shibabaw, et al.
Published: (2023-03-01)

Mast Cells as a Target—A Comprehensive Review of Recent Therapeutic Approaches
by: Joanna Baran, et al.
Published: (2023-04-01)

Elevated type-17 cytokines are present in Axial Spondyloarthritis stool
by: Brough, I, et al.
Published: (2024)

Th17-associated cytokines IL-17 and IL-23 in inflamed skin of Darier disease patients as potential therapeutic targets
by: Monika Ettinger, et al.
Published: (2023-11-01)

The Role of IL-17-Producing Cells in Cutaneous Fungal Infections
by: Yu Sawada, et al.
Published: (2021-05-01)

Marking and quantifying IL-17A-producing cells in vivo.
by: April E Price, et al.
Published: (2012-01-01)